Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Alec Machiels currently holds 5,748 shares of Apellis Pharmaceuticals, Inc. (APLS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alec Machiels has been a net seller of APLS stock. They have purchased $0 and sold $4.1M worth of shares.
Alec Machiels's most recent insider trade was on Jan 1, 2024, when they sold 5,748 shares at $59.86 per share.
Alec Machiels serves as Executive at Apellis Pharmaceuticals, Inc. (APLS). They have executed 101 insider transactions totaling $4.1M over their tenure at the company.
Alec Machiels holds the position of Executive at Apellis Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Alec Machiels has shown a selling trading pattern, with $0 in total purchases and $4.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Alec Machiels was on Jan 1, 2024, when they purchased $344.1K worth of APLS shares. This transaction involved 5,748 shares at $59.86 per share.
Alec Machiels currently owns 5,748 shares of Apellis Pharmaceuticals, Inc. (APLS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Alec Machiels's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Alec Machiels has 101 Form 4 filings on record as an insider at Apellis Pharmaceuticals, Inc..
Set alerts for Alec Machiels and 40,000+ other insiders.